After two brutal trading days wiped out more than $5 trillion in U.S. equity value, investment firm Evercore ISI has scaled back its expectations for the S&P 500 in 2025, acknowledging that prior ...
Evercore ISI upgraded shares of Genuine Parts (NYSE:GPC – Free Report) from an in-line rating to an outperform rating in a ...
3d
Fintel on MSNEvercore ISI Group Upgrades Genuine Parts (GPC)Fintel reports that on April 4, 2025, Evercore ISI Group upgraded their outlook for Genuine Parts (NYSE:GPC) from In-Line to ...
Market uncertainty should "peak" around the Wednesday tariff deadline, according to Evercore ISI. In a note this week, Julian ...
JPMorgan Chase & Co. (NYSE:JPM) had its target price reduced by Evercore ISI from $273.00 to $265.00 in a research note ...
Evercore ISI notes that Vaxcyte (PCVX) missed four serotypes versus Prevnar20 in the “all-important” infant data, adding that ...
Explore more
Evercore ISI analyst Greg Melich upgraded Genuine Parts (GPC) to Outperform from In Line with a price target of $135, up from $128. The ...
Evercore ISI downgraded Sensata (ST) to In Line from Outperform with a price target of $27, down from $40. The firm thinks the turnaround that Sensata is undertaking will become more difficult in ...
While the mid-year reinsurance renewals are forecast to see further softening of between 5% and 10% as a base case, according ...
Analysts at JPMorgan and Morgan Stanley point to seasonal factors and investor sentiment as they forecast a period of calm.
Fintel reports that on April 4, 2025, Evercore ISI Group upgraded their outlook for Genuine Parts (LSE:0IUX) from In-Line to Outperform. As of April 2, 2025, the average one-year price target for ...
Fintel reports that on April 4, 2025, Evercore ISI Group upgraded their outlook for Genuine Parts (NYSE:GPC) from In-Line to Outperform. As of April 2, 2025, the average one-year price target for ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results